Here are relevant reports on : ai-route-planning-market
-
Web Content Management (WCM) Market by Product Type (Content Management (AI image generation, AI voice generation), Digital Asset Management, Content Marketing, Website Development), Architecture (Coupled, Decoupled, Hybrid) - Global Forecast to 2029
The web content management (WCM) market is projected to reach USD 24.97 billion by 2029, at a CAGR of 18.6% during the forecast period. The major web content management providers include Adobe (US), Oracle (US), Microsoft (US), OpenText (Canada), Automattic (US), Canva (US), OpenAI (US). These companies have used both organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to strengthen their position in the web content management market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
AI for Customer Service Market by Product Type (AI Agents, Recommendation Systems (Knowledge Base Platforms), Workflow Automation (RPA, CRM Automation), Content Generation, Customer Journey Analytics, Service Quality Management) - Global Forecast to 2030
The AI for customer service market is projected to reach USD 47.82 billion by 2030, at a CAGR of 25.8% during the forecast period. Some major players in the AI for customer service Market include Microsoft (US), IBM (US), Google (US), AWS (US), Salesforce (US), Atlassian (Australia), ServiceNow (US), SAP (Germany), Zendesk (US), Sprinklr (US), OpenAI (US), Aisera (US), UiPath (US), HubSpot (US), NICE (Israel), Intercom (US),Qualtrics (US), Freshworks (US), LivePerson (US), HelpShift (US), Yellow.ai (US), Cogito (US), SmartAction (US), Talkdesk (US), Five9 (US), RingCentral (US), Nextiva (US), Kore.ai (US), Dynamic Yield (US), Jio Haptik (India), Oracle (US), Afiniti (Bermuda), Kommunicate (US), Help Scout (US), Gorgias (US), Atera (Israel), Ada (US), Kustomer (US), Levity (Germany), Cognigy (Germany), Engageware (US), Netomi (US), Level AI (US), Sybill AI (US), OneAI (US), Brainfish (Australia), SentiSum (England), Balto (US), Tovie AI (UK), Guru (US), Tidio (US), Quiq (US), Aircall (US), OneReach.ai (US), Cresta (US), Deepdesk (Netherlands), Front (US), Fullview (Denmark), Crescendo AI (US), Gridspace (US).
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Cloud AI Market by Cloud AI Infrastructure (Compute, Storage, Network), AI & ML Platforms (Auto ML), MLOps and Lifecycle Management (AI Workflow Orchestration), AIaaS, Technology (Generative AI and Other AI) - Global Forecast to 2029
The global cloud AI market is projected to reach USD 327.15 billion by 2029 at a CAGR of 32.4 % during the forecast period. Some of the significant cloud AI vendors include Google (US), IBM (US), AWS (US), Microsoft (US), Oracle (US), NVIDIA (US), Salesforce (US), SAP (Germany), Alibaba Cloud (China), HPE (US), and Intel (US).
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
AI Platform Market by Offering (Conversational AI, Generative AI, AI Agent, Deep Learning, Edge AI, AI API, MLOps, Data Mesh, Data Science Platforms), Functionality (Data Management, Model Development, Deployment, Training) - Global Forecast to 2030
The AI platform market is witnessing strong growth, projected to rise from around USD 18.22 billion in 2025 to over USD 94.31 billion by 2030, registering a CAGR of nearly 38.9% during the forecast period. The major players in the AI platform market include Google (US), Microsoft (US), IBM (US), AWS (US), Oracle (US), SAP (Germany), OpenAI (US), Intel (US), Infosys (India), and Wipro (India).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
US Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injectable, Topical (Cream, Transdermal, Suppositories), Ocular, Nasal, Transmucosal, Implantable], Application (Cancer, Diabetes), Care Setting - Forecast to 2031
The US pharmaceutical drug delivery market, valued at US$0.91 billion in 2025, stood at US$0.94 billion in 2026 and is projected to advance at a resilient CAGR of 5.8% from 2026 to 2031, culminating in a forecasted valuation of US$1.24 billion by the end of the period. The market growth trend is fueled by several factors. One of the primary drivers is the quick and extensive rise of biologics and biosimilars, necessitating advanced injectable and large-volume delivery systems.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Monoclonal Antibody Therapeutics Market / mABs Therapeutics Market Size by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
The global monoclonal antibody therapeutics market, valued at US$222.6 billion in 2023, stood at US$252.6 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$497.5 billion by the end of the period. Driving factors of the market, including clinical trials, encompass increasing prevalence of complex diseases, advancements in biotechnology facilitating targeted treatments, regulatory support expediting approval processes, and robust investments in research and development.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Vascular Access Device Market Type [Central, Peripheral (Venous {PIVC, Midline}, Arterial), Intraosseous], Route of Insertion, Application [Chemotherapy, Fluid Administration, Diagnostic], End User [Hospital (Public, Private)] - Global Forecast to 2031
The global vascular access device market is projected to reach USD 8.70 billion by 2031, growing at a CAGR of 6.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Poultry Medicine/Pharmaceuticals Market by Animal Type (Chickens, Turkeys, Ducks), Product (Drugs, Vaccines, Feed Additives), Disease Indication (Newcastle disease, Infectious Bursal Disease, Salmonella), Route of Administration - Global Forecast to 2029
The global poultry medicine/pharmaceuticals market, valued at US$4.73 billion in 2023, stood at US$5.01 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$6.68 billion by the end of the period. The growth of the poultry medicine/pharmaceutical industry can be attributed to the rising global population and consumption of poultry meat and eggs leading to more poultry farming practiced notably in the developing regions where poultry is the cheapest source of protein.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027
Veterinary pain management market growth is primed to transition from $1.8 billion in 2022 to $2.5 billion by 2027, showcasing a strong CAGR of 6.7%. Factors such as growth in companion animal adoption, the increasing number of veterinary practitioners and their rising income levels in developed economies, increasing consumption of meat & milk, the growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of this market.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028
The global veterinary API market, valued at US$8.0 billion in 2022, stood at US$8.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$11.9 billion by the end of the period. The veterinary active pharmaceutical ingredient (API) market is growing due to various factors, including the increased occurrence of transboundary and zoonotic diseases, a rise in the global animal population and pet ownership, and the implementation of improved disease control and prevention measures.
- Published: June 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
